Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Laskow-Pooley David, Director. Director active across 2 companies, notably Marker Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. History available since 8 June 2021. The latest transaction was filed on 8 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
David Laskow-Pooley is a Director at Marker Therapeutics, Inc., a company specializing in cell therapies. In this role, he contributes to the governance of the company and the development of its strategy. Laskow-Pooley brings expertise in biotechnology and research, allowing him to play a key role in strategic decision-making. His commitment to innovation and improving healthcare is central to his mission.